Accreditation and External Quality Assessment

Accreditation

The Department of Molecular Genetics at the Royal Devon and Exeter Hospital is a UKAS accredited medical laboratory No.:8092 (see UKAS certificate 2015).

External Quality Assessment

The laboratory participates in UK NEQAS and EMQN schemes, where available. Please see our UK NEQAS participation certificates for Molecular Pathology and Molecular Genetics.

A list of the schemes we participate in can be found below:

Scheme  Assessor Results 2014-2015 Results 2015-2016
 Sanger DNA Sequencing Scheme  EMQN  Satisfactory performance Satisfactory performance
 Haemochromatosis  EMQN Satisfactory performance Satisfactory performance
 Lung Cancer  EMQN Satisfactory performance Satisfactory performance
 Multiple Endocrine Neoplasia type 2  EMQN Satisfactory performance Satisfactory performance
 Monogenic Diabetes  EMQN Satisfactory performance Satisfactory performance
 Von-Hippel Lindau  EMQN and UKNEQAS Molecular Genetics Satisfactory performance (EMQN) Satisfactory performance (NEQAS)
 Next Generation Sequencing Pilot Scheme  EMQN Satisfactory performance Satisfactory performance
 Cystic Fibrosis UKNEQAS Molecular Genetics Satisfactory performance Satisfactory performance
 Maternal Cell Contamination UKNEQAS Molecular Genetics Satisfactory performance Satisfactory performance
 Mitochondrial diseases (MIDD and MELAS only) UKNEQAS Molecular Genetics Satisfactory performance Satisfactory performance
 Pathogenicity of sequence variants interpretation Pilot Scheme UKNEQAS Molecular Genetics Satisfactory performance Satisfactory performance
Report authorisation  Pilot Scheme UKNEQAS Molecular Genetics Satisfactory performance Satisfactory performance
 HLA-B27 UKNEQAS H&I Satisfactory performance Satisfactory performance
 Melanoma UKNEQAS Molecular Pathology Satisfactory performance Satisfactory performance
 Colorectal Cancer (KRAS and NRAS) UKNEQAS Molecular Pathology Satisfactory performance Satisfactory performance
 Gastrointestinal Stromal tumour UKNEQAS Molecular Pathology Satisfactory performance Test no longer done
 Thrombophilia UKNEQAS Blood Coagulation Satisfactory performance Satisfactory performance
 BCR-ABL and AML Translocation Identification (AML) UKNEQAS  Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
 BCR-ABL Quantitation UKNEQAS Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
 IgH/TCR Clonality status (IgH) UKNEQAS Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
 JAK2 V617F Mutation Status (JAK2) UKNEQAS Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
 BCR-ABL Kinase Domain Mutation Status (KDM) UKNEQAS Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
 Minor BCR-ABL1 Quantitation UKNEQAS Leukocyte Immunophenotyping (LI) N/A Satisfactory performance
BCR-ABL1 Quantification  UKNEQAS Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
 BRAF V600E for Hairy Cell Leukaemia Mutation Status (BRAF) Pilot Scheme UKNEQAS Leukocyte Immunophenotyping (LI) Satisfactory performance Satisfactory performance
KIT D816V Mutation Status (KIT) Pilot Scheme UKNEQAS Leukocyte Immunophenotyping (LI) Unsatisfactory Satisfactory performance
Molecular Tissue Identification Pilot scheme UKNEQAS Molecular Pathology N/A Satisfactory performance